We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$334M
AUM Growth
+$12.7M
Cap. Flow
-$8.55M
Cap. Flow %
-2.56%
Top 10 Hldgs %
34.49%
Holding
217
New
11
Increased
36
Reduced
117
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 18.1%
2 Technology 16.4%
3 Financials 12.44%
4 Industrials 9.27%
5 Communication Services 6.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
26
ExxonMobil
XOM
$635B
$2.84M 0.85%
24,420
+35
+0.1% +$3.66K
RTX icon
27
RTX Corp
RTX
$289B
$2.8M 0.84%
28,717
-970
-3% -$87.6K
LIN icon
28
Linde
LIN
$222B
$2.66M 0.8%
5,737
-379
-6% -$164K
WMT icon
29
Walmart Inc
WMT
$887B
$2.64M 0.79%
43,888
-4,160
-9% -$238K
VCSH icon
30
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.49M 0.75%
32,190
-2,215
-6% -$171K
PG icon
31
Procter & Gamble
PG
$335B
$2.45M 0.73%
15,077
-605
-4% -$94.9K
META icon
32
Meta Platforms (Facebook)
META
$1.39T
$2.44M 0.73%
5,021
-232
-4% -$103K
CVS icon
33
CVS Health
CVS
$134B
$2.43M 0.73%
30,455
-50
-0.2% -$3.82K
VBR icon
34
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$2.42M 0.73%
12,635
-285
-2% -$51.4K
SBUX icon
35
Starbucks
SBUX
$120B
$2.42M 0.72%
26,477
-2,135
-7% -$199K
ATRI
36
DELISTED
Atrion Corp
ATRI
$2.38M 0.71%
5,145
-181
-3% -$67.9K
AMGN icon
37
Amgen
AMGN
$207B
$2.37M 0.71%
8,327
-132
-2% -$38.6K
NVDA icon
38
NVIDIA
NVDA
$4.76T
$2.35M 0.7%
26,040
-1,140
-4% -$82.6K
CNC icon
39
Centene
CNC
$30.8B
$2.34M 0.7%
29,784
-220
-0.7% -$17K
UNP icon
40
Union Pacific
UNP
$174B
$2.3M 0.69%
9,332
-143
-2% -$35.2K
MGV icon
41
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
$2.28M 0.68%
19,098
-634
-3% -$71.8K
VIG icon
42
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.25M 0.67%
12,298
-15
-0.1% -$2.63K
WIW
43
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$507M
$2.2M 0.66%
255,019
-47,599
-16% -$409K
DIS icon
44
Walt Disney
DIS
$167B
$2.1M 0.63%
17,161
-306
-2% -$32K
BDX icon
45
Becton Dickinson
BDX
$45.3B
$2.06M 0.62%
8,339
-253
-3% -$60.6K
DGX icon
46
Quest Diagnostics
DGX
$25.9B
$2.03M 0.61%
15,224
-295
-2% -$38.3K
MEDP icon
47
Medpace
MEDP
$15.9B
$1.92M 0.58%
4,762
-668
-12% -$235K
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$120B
$1.92M 0.57%
4,585
-272
-6% -$115K
TECH icon
49
Bio-Techne
TECH
$11.2B
$1.84M 0.55%
26,080
-28
-0.1% -$2K
INTU icon
50
Intuit
INTU
$86.2B
$1.81M 0.54%
2,779
-15
-0.5% -$9.57K

Similar funds

Roberts, Glore & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Roberts, Glore & Co held 217 positions worth $334M, up 4% from $321M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Roberts, Glore & Co's Q1 2024 filing shows 11 new, 36 increased, 117 reduced and 8 closed positions. Its largest new stake was AMN Healthcare: 7,170 shares worth $448K. The largest sale was Splunk Inc, an estimated $1.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q1 2024 buy was AMN Healthcare: 7,170 shares worth $448K.
  • Roberts, Glore & Co added most to Vanguard Tax-Exempt Bond Index Fund in Q1 2024, an estimated $711K increase.
  • Roberts, Glore & Co's biggest Q1 2024 reduction was Microsoft, cutting an estimated $1.11M.
  • Roberts, Glore & Co fully exited Splunk Inc in Q1 2024, selling an estimated $1.2M.
  • Roberts, Glore & Co's ten largest holdings make up 34% of its $334M portfolio in Q1 2024.
  • Roberts, Glore & Co opened 11 new positions and closed 8 in Q1 2024.
  • Roberts, Glore & Co's portfolio value rose 4% quarter-over-quarter to $334M.

Based on Roberts, Glore & Co's 13F filing for Q1 2024, filed 9 May 2024.